Chugai Pharmaceutical Co., Ltd.
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
0.20
Price/Sales ratio
N/A
Earnings per Share (EPS)
$108.98

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
31.6038.0535.3343.2637.7117.5021.0210.217.2913.3216.4617.50
Price/Sales ratio
3.494.663.855.886.014.015.733.092.163.9010.776.01
Price/Book Value ratio
2.703.712.934.544.613.224.602.601.912.663.333.33
Price/Cash Flow ratio
43.5136.9648.8229.2229.2913.3422.0111.0711.1910.5817.8017.80
Price/Free Cash Flow ratio
90.1961.77800.7349.8584.2518.9531.4214.9715.8012.9243.9543.95
Price/Earnings Growth ratio
492.481.92-2.841.211.400.070.580.240.31-1.01-0.010.07
Dividend Yield
1.52%1.21%1.67%0.95%1.00%2.04%2.02%3.18%5.05%3.03%0.62%2.04%
Profitability Indicator Ratios
Gross Profit Margin
52.70%51.84%49.58%52.42%54.66%61.22%65.24%66.17%62.20%62.81%69.46%54.66%
Operating Profit Margin
16.45%17.39%15.63%18.52%21.44%30.69%38.27%42.19%42.32%39.51%44.33%21.44%
Pretax Profit Margin
16.51%17.49%15.13%18.16%20.94%30.29%37.89%41.94%42.15%39.93%45.07%20.94%
Net Profit Margin
11.05%12.25%10.89%13.61%15.95%22.96%27.28%30.30%29.71%29.28%32.73%15.95%
Effective Tax Rate
31.62%28.55%26.96%24.20%23.35%24.21%27.98%27.75%29.50%26.66%27.37%23.35%
Return on Assets
6.89%7.76%6.64%8.52%10.05%14.87%17.38%19.69%20.02%16.84%17.23%10.05%
Return On Equity
8.55%9.76%8.30%10.50%12.23%18.45%21.91%25.50%26.28%20.02%21.66%12.23%
Return on Capital Employed
12.13%13.26%11.26%13.56%15.85%23.94%30.14%34.83%36.88%26.70%27.16%15.85%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A5.08N/A
Quick Ratio
3.493.053.183.493.252.962.752.612.463.794.173.25
Cash ratio
0.990.760.771.131.081.130.890.810.521.591.351.08
Days of Sales Outstanding
126.56116.13124.30119.57113.0396.61117.50129.63148.47104.73117.67113.03
Days of Inventory outstanding
233.60244.81272.98242.77221.29230.63245.44225.42223.94241.51292.81221.29
Operating Cycle
360.16360.94397.29362.34334.33327.25362.95355.05372.42346.24410.48334.33
Days of Payables Outstanding
31.41119.04106.5091.2199.57106.50134.00164.35160.8199.3287.00106.50
Cash Conversion Cycle
328.75241.90290.79271.12234.75220.75228.95190.70211.60246.92323.47234.75
Debt Ratios
Debt Ratio
0.000.000.000.00N/AN/AN/AN/AN/AN/AN/AN/A
Debt Equity Ratio
0.000.000.000.00N/AN/AN/AN/AN/AN/AN/AN/A
Long-term Debt to Capitalization
0.000.000.000.00N/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
0.000.000.000.00N/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A26.71KN/A
Cash Flow to Debt Ratio
173.0585.6060.13320.30N/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
1.241.251.241.231.211.231.261.291.311.181.171.23
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.080.120.070.200.200.300.260.270.190.360.300.20
Free Cash Flow / Operating Cash Flow Ratio
0.480.590.060.580.340.700.700.730.700.810.810.34
Cash Flow Coverage Ratio
173.0585.6060.13320.30N/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
1.27K480.29287.31834.28N/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
48.09%46.42%59.10%41.33%37.85%35.77%42.58%32.55%36.91%40.43%36.97%36.97%